BioLife Solutions Statistics
Total Valuation
BLFS has a market cap or net worth of $718.46 million. The enterprise value is $709.42 million.
| Market Cap | 718.46M |
| Enterprise Value | 709.42M |
Important Dates
The next estimated earnings date is Wednesday, May 8, 2024, after market close.
| Earnings Date | May 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BLFS has 45.30 million shares outstanding. The number of shares has increased by 2.91% in one year.
| Shares Outstanding | 45.30M |
| Shares Change (YoY) | +2.91% |
| Shares Change (QoQ) | +2.89% |
| Owned by Insiders (%) | 3.54% |
| Owned by Institutions (%) | 102.44% |
| Float | 32.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 250.00 |
| PS Ratio | 5.01 |
| Forward PS | 6.29 |
| PB Ratio | 2.13 |
| P/FCF Ratio | n/a |
| PEG Ratio | 65.38 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.86, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.86 |
| Quick Ratio | 1.67 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -35.57 |
Financial Efficiency
Return on equity (ROE) is -19.30% and return on invested capital (ROIC) is -19.20%.
| Return on Equity (ROE) | -19.30% |
| Return on Assets (ROA) | -15.60% |
| Return on Capital (ROIC) | -19.20% |
| Revenue Per Employee | $350,296 |
| Profits Per Employee | -$162,413 |
| Employee Count | 409 |
| Asset Turnover | 0.34 |
| Inventory Turnover | 2.46 |
Taxes
In the past 12 months, BLFS has paid $169,000 in taxes.
| Income Tax | 169,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.86% in the last 52 weeks. The beta is 1.69, so BLFS's price volatility has been higher than the market average.
| Beta (1Y) | 1.69 |
| 52-Week Price Change | -19.86% |
| 50-Day Moving Average | 17.46 |
| 200-Day Moving Average | 15.37 |
| Relative Strength Index (RSI) | 40.50 |
| Average Volume (30 Days) | 368,529 |
Short Selling Information
The latest short interest is 3.20 million, so 7.06% of the outstanding shares have been sold short.
| Short Interest | 3.20M |
| Short Previous Month | 3.03M |
| Short % of Shares Out | 7.06% |
| Short % of Float | 9.80% |
| Short Ratio (days to cover) | 7.28 |
Income Statement
In the last 12 months, BLFS had revenue of $143.27 million and -$66.43 million in losses. Loss per share was -$1.52.
| Revenue | 143.27M |
| Gross Profit | 46.75M |
| Operating Income | -73.02M |
| Pretax Income | -66.26M |
| Net Income | -66.43M |
| EBITDA | -51.75M |
| EBIT | -64.45M |
| Loss Per Share | -$1.52 |
Balance Sheet
The company has $51.73 million in cash and $42.69 million in debt, giving a net cash position of $9.04 million or $0.20 per share.
| Cash & Cash Equivalents | 51.73M |
| Total Debt | 42.69M |
| Net Cash | 9.04M |
| Net Cash Per Share | $0.20 |
| Equity / Book Value | 337.66M |
| Book Value Per Share | 7.45 |
| Working Capital | 78.43M |
Cash Flow
In the last 12 months, operating cash flow was -$12.50 million and capital expenditures -$11.24 million, giving a free cash flow of -$23.74 million.
| Operating Cash Flow | -12.50M |
| Capital Expenditures | -11.24M |
| Free Cash Flow | -23.74M |
| FCF Per Share | -$0.54 |
Margins
Gross margin is 32.63%, with operating and profit margins of -50.96% and -46.36%.
| Gross Margin | 32.63% |
| Operating Margin | -50.96% |
| Pretax Margin | -46.25% |
| Profit Margin | -46.36% |
| EBITDA Margin | -36.12% |
| EBIT Margin | -44.98% |
| FCF Margin | -16.57% |
Dividends & Yields
BLFS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.91% |
| Shareholder Yield | -2.91% |
| Earnings Yield | -9.25% |
| FCF Yield | -3.30% |
Analyst Forecast
The average price target for BLFS is $24.80, which is 56.37% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24.80 |
| Price Target Difference | 56.37% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 15.48% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 29, 2014. It was a reverse split with a ratio of 1:14.
| Last Split Date | Jan 29, 2014 |
| Split Type | Reverse |
| Split Ratio | 1:14 |
Scores
BLFS has an Altman Z-Score of 4.74 and a Piotroski F-Score of 3.
| Altman Z-Score | 4.74 |
| Piotroski F-Score | 3 |